Cardiac involvement in a patient with B-cell lymphoblastic lymphoma/acute lymphoblastic leukemia and a history of allogeneic hematopoietic stem cell transplantation and CAR T-cell therapy: A case report

被引:1
|
作者
Cao, Yigeng [1 ,2 ]
Liu, Yadan [3 ]
Zhang, Rongli [1 ,2 ]
Zhai, Weihua [1 ,2 ]
Ma, Qiaoling [1 ,2 ]
Wei, Jialin [1 ,2 ]
Yang, Donglin [1 ,2 ]
Pang, Aiming [1 ,2 ]
He, Yi [1 ,2 ]
Chen, Xin [1 ,2 ]
Jiang, Erlie [1 ,2 ]
Feng, Sizhou [1 ,2 ]
Han, Mingzhe [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China
[3] Ningbo First Hosp, Ningbo Clin Res Ctr Hematol Malignancies, Hematol Dept, Ningbo, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 13卷
关键词
B cell acute lymphoblastic leukemia; B cell lymphoblastic lymphoma; allogeneic hematopoietic stem cell transplantation; chimeric antigen receptor T cells; cardiac involvement; MANAGEMENT; DIAGNOSIS; NEOPLASMS;
D O I
10.3389/fimmu.2022.1052336
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cardiac involvement in hematological malignancies is uncommon, with only a few cases reported to date, and it often leads to a poor prognosis. Here, we report a case of a 42-year-old woman with a history of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for B-cell lymphoblastic lymphoma/acute lymphoblastic leukemia in whom cardiac mass and myocardial infiltration were detected. Prior to this presentation, massive pericardial effusion had occurred 6 months after CAR T-cell therapy, which was improved via ultrasound-guided pericardiocentesis. We observed elevated cytokine levels and increased copy number of CAR DNA in both pericardial effusion and serum. Upon detecting cardiac mass and myocardial infiltration, the patient was administered tocilizumab (a humanized monoclonal antibody against IL-6 receptor), which controlled the serum cytokine levels, and reduced intensity chemotherapy, including vindesine, cyclophosphamide, and prednisolone. However, the patient finally died of multiple organ failure. To the best of our knowledge, this is the first report on the development of a cardiac mass and occurrence of myocardial infiltration after allo-HSCT and CAR T-cell therapy. This report may provide supporting data for the early diagnosis and immediate treatment of patients with cardiac involvement.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Extensive Extramedullary Involvement at Presentation in B-Cell Acute Lymphoblastic Leukemia
    Sharma, Siddharth
    Singh, Vijay
    Ora, Manish
    Nazar, Aftab Hasan
    Gambhir, Sanjay
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (06) : E300 - E301
  • [42] Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation
    Zhang, Rongli
    He, Yi
    Yang, Donglin
    Wang, Ying
    Feng, Sizhou
    Wang, Jianxiang
    Han, Ming-Zhe
    BLOOD, 2018, 132
  • [43] Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia
    Veltri, Giulia
    Lovisa, Federica
    Cortese, Giuliana
    Pillon, Marta
    Carraro, Elisa
    Cesaro, Simone
    Provenzi, Massimo
    Buffardi, Salvatore
    Francescato, Samuela
    Biffi, Alessandra
    Buldini, Barbara
    Conter, Valentino
    Serafin, Valentina
    Mussolin, Lara
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Chieh-Lin Jerry Teng
    Jui-Ting Yu
    Hung-Chieh Chen
    Wen-Li Hwang
    Annals of Hematology, 2013, 92 : 1137 - 1139
  • [45] Chimeric Antigen Receptor T Cells for B-Cell Acute Lymphoblastic Leukemia
    Ceppi, Francesco
    Gardner, Rebecca A.
    CANCER JOURNAL, 2019, 25 (03) : 191 - 198
  • [46] Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Acute Leukemia
    Ram Vasudevan Nampoothiri
    Auro Viswabandya
    Indian Journal of Hematology and Blood Transfusion, 2021, 37 : 521 - 527
  • [47] CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia
    Singh, Nathan
    Frey, Noelle V.
    Grupp, Stephan A.
    Maude, Shannon L.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (06)
  • [48] Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation
    Xiao, Haowen
    Wang, Li-Mengmeng
    Luo, Yi
    Lai, Xiaoyu
    Li, Caihua
    Shi, Jimin
    Tan, Yamin
    Fu, Shan
    Wang, Yebo
    Zhu, Ni
    He, Jingsong
    Zheng, Weiyan
    Yu, Xiaohong
    Cai, Zhen
    Huang, He
    ONCOTARGET, 2016, 7 (03) : 2696 - 2708
  • [49] Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Acute Leukemia
    Vasudevan Nampoothiri, Ram
    Viswabandya, Auro
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2021, 37 (04) : 521 - 527
  • [50] Central Nervous System Relapse in Adults with Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Hamdi, Amir
    Mawad, Raya
    Bassett, Roland
    di Stasi, Antonio
    Ferro, Roberto
    Afrough, Aimaz
    Ram, Ron
    Dabaja, Bouthaina
    Rondon, Gabriela
    Champlin, Richard
    Sandmaier, Brenda M.
    Doney, Kristine
    Bar, Merav
    Kebriaei, Partow
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1767 - 1771